Your browser doesn't support javascript.
loading
Medical and procedural treatment of androgenetic alopecia - Where are we?
Ly, Nathalie Y; Fruechte, Sophia; Hordinsky, Maria K; Sadick, Neil; Arruda, Suleima; Farah, Ronda S.
Affiliation
  • Ly NY; Department of Dermatology, University of Minnesota, Minneapolis, Minnesota; Ohio State University College of Medicine, Columbus, Ohio.
  • Fruechte S; Department of Dermatology, University of Minnesota, Minneapolis, Minnesota; Des Moines University College of Osteopathic Medicine, Des Moines, Iowa.
  • Hordinsky MK; Department of Dermatology, University of Minnesota, Minneapolis, Minnesota.
  • Sadick N; Department of Dermatology, University of Minnesota, Minneapolis, Minnesota; Weill Cornell Medical College, New York, New York; Sadick Dermatology, New York, New York.
  • Arruda S; Sadick Dermatology, New York, New York.
  • Farah RS; Department of Dermatology, University of Minnesota, Minneapolis, Minnesota; Department of Dermatology, Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota. Electronic address: rfarah@umn.edu.
J Am Acad Dermatol ; 89(2S): S36-S39, 2023 08.
Article in En | MEDLINE | ID: mdl-37591565
Novel medical and procedural options for androgenetic alopecia have arrived. Low-dose oral minoxidil has made its clinical debut, while data on spironolactone, finasteride, and nutritional supplements have advanced. Minimally invasive technological advancements include photobiomodulation and platelet-rich plasma. Within hair transplantation, follicular unit extraction and robotics are now at the clinicians' fingertips.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Finasteride / Alopecia Language: En Journal: J Am Acad Dermatol Year: 2023 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Finasteride / Alopecia Language: En Journal: J Am Acad Dermatol Year: 2023 Type: Article